EXHIBIT 3.6

                    THIRD AMENDMENT TO ALLERGAN, INC. BYLAWS

The ALLERGAN, INC. BYLAWS (the "Bylaws") are hereby amended as follows:

         1.       Article III, Section 14 of the Bylaws is amended in its
entirety as follows:

                  SECTION 14. Definition of Independent Director. For purposes
         of this Article III, the term "Independent Director" shall mean:

                  (A) for purposes of determining whether a director is
         qualified to serve as a member of the audit committee of the Board, a
         director who meets the qualification requirements for being an
         independent director under applicable securities laws, including the
         Securities Exchange Act of 1934, applicable rules and regulations of
         the Securities and Exchange Commission and applicable rules and
         regulations of The New York Stock Exchange; and

                  (B) for all other purposes, a director who meets the
         qualification requirements for being an independent director under
         applicable rules and regulations of The New York Stock Exchange.

         2.       The effective date of this Second Amendment shall be January
26, 2004.

         IN WITNESS WHEREOF, Allergan, Inc. hereby executes this Third Amendment
on the 6th day of February, 2004.

ALLERGAN, INC.

By:  /s/ Douglas S. Ingram
    --------------------------------
     Douglas S. Ingram
     Executive Vice President,
     General Counsel and Secretary